Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEXIDARTINIB vs PHENOLPHTHALEIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEXIDARTINIB vs PHENOLPHTHALEIN: Safety Overview

Metric PEXIDARTINIB PHENOLPHTHALEIN
Total FAERS Reports 970 106
Deaths Reported 17 2
Death Rate 1.8% 1.9%
Hospitalizations 91 87
Average Patient Age 44.9 yrs 71.3 yrs
% Female Patients 63.4% 88.8%
FDA Approval Date Aug 2, 2019 N/A
Manufacturer Daiichi Sankyo Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A